Information Provided By: 
Fly News Breaks for July 28, 2016
ORA, STMP, SMCI, FATE, CRAY
Jul 28, 2016 | 10:33 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cray (CRAY) initiated with an Overweight at Pacific Crest. 2. Fate Therapeutics (FATE) assumed with a Buy at H.C. Wainwright. 3. Super Micro Computer (SMCI) initiated with a Sector Weight at Pacific Crest. 4. Stamps.com (STMP) re-initiated with a Buy at Roth Capital. 5. Ormat Technologies (ORA) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For CRAY;FATE;SMCI;STMP;ORA From the Last 2 Days
SMCI
Apr 16, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include UnitedHealth (UNH) $475.73 +30.10, Super Micro (SMCI) $914.90 +32.15, Humana (HUM) $324.54 +9.90, Morgan Stanley (MS) $89.42 +2.43, and Cencora Inc (COR) $238.39 +4.18.
SMCI
Apr 16, 2024 | 06:00 EDT
Loop Capital raised the firm's price target on Supermicro to $1,500 from $600 and keeps a Buy rating on the shares. The firm continues to gain confidence in both its "net-bullish" generative artificial intelligence server industry posture and Supermicro as an increasing leader in the need for both complexity and scale. The analyst thinks a 20- to 30-times price-to-earnings multiple for shares is maintainable now that the company is in the S&P 500 Index. It thinks the company can have a $40B revenue run-rate exiting fiscal 2026.
